Oscars 2027: Best Original Song Nominations

The current setup is favorable for Yes, but not overwhelming. La Nieve is being treated as a serious early contender by multiple forecasting signals, and the film around it is also drawing Oscar-season attention, which matters in a category where campaigning, visibility, and narrative momentum often help shape the final field. The song also appears to have the kind of artist identity and prestige association that can resonate with voters, especially if the campaign frames it as an emotionally distinctive piece tied to a buzzy film. That said, this remains very early in the season, and the difference between being discussed as a contender and actually landing a nomination is still large.

The main reason to avoid overpricing Yes is that the market evidence is mixed. One source of sentiment puts the song at about 60%, which is solid but not dominant, while the broader market is even more enthusiastic at 87.5%. That gap suggests traders may be leaning heavily on current buzz rather than hard evidence of Academy support. In an original song race, early leaders can easily slip if another film mounts a stronger campaign, if an eligible song becomes clearer as the studio push coalesces, or if the Academy gravitates toward a more obvious crowd-pleasing option from a bigger commercial property. The presence of strong competition from high-profile films means La Nieve must survive not only quality scrutiny but also campaign timing and voter familiarity.

Historical and structural considerations also argue for caution. Best Original Song nominations often reward a blend of visibility, industry backing, memorable standalone appeal, and a clean awards-season narrative. At this point, La Nieve seems to have the first two, but the latter two are not guaranteed. If The Black Ball maintains momentum through the fall and winter, the song could absolutely remain in the conversation, but early forecasts are notoriously unstable this far from nomination voting. My view is that the song is a legitimate contender with a better-than-even chance, yet the current price is somewhat inflated relative to the uncertainty that still surrounds submissions, campaigning, and final Academy taste.